SCHEMBL20164144

SCHEMBL20164144

C=CCC(NC(=O)O)C(=O)NC(C)c1ccccc1NC(=O)C(C)C=C

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
LPAR1 Q92633 1/20 0.34
MMP2 P08253 6/20 0.34
MMP3 P08254 6/20 0.34
MMP7 P09237 5/20 0.34
MMP1 P03956 5/20 0.33
MMP8 P22894 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MMP9 P14780 2/20 0.33
MMP14 P50281 2/20 0.33
ADAM17 P78536 1/20 0.33
ANPEP P15144 1/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
NLRP3 Q96P20 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20164143 1.00 NPSR1 (0.34) NPSR1L3MBTL1LPAR1MMP2MMP3
SCHEMBL20164151 1.00 NPSR1 (0.34) NPSR1L3MBTL1LPAR1MMP2MMP3
SCHEMBL21442825 0.86 MAPT (0.47)
SCHEMBL20181112 0.86 MAPT (0.47)
SCHEMBL20164145 0.81 L3MBTL1 (0.41) NPSR1L3MBTL1MMP2MMP3MMP7
SCHEMBL20164142 0.81 L3MBTL1 (0.41) NPSR1L3MBTL1MMP2MMP3MMP7
SCHEMBL20164187 0.80 KDM4E (0.37) MMP2MMP3MMP7MMP1MMP8
SCHEMBL20164184 0.80 KDM4E (0.37) MMP2MMP3MMP7MMP1MMP8
SCHEMBL20164165 0.76 ALDH1A1 (0.42) ALDH1A1POLB
SCHEMBL20164163 0.76 ALDH1A1 (0.42) ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108026083-B Diamide macrocycles as factor XIA inhibitors 百时美施贵宝公司 2021-08-27 CN disclosed
EP-3310777-B1 DIAMIDE MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2019-10-09 EP disclosed
US-10160750-B2 Diamide macrocycles as factor XIa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2018-12-25 US disclosed
US-20180141932-A1 DIAMIDE MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141932-A1 DIAMIDE MACROCYCLES AS FACTOR XIA INHIBITORS TFPI, TFPI2, F11 NPSR1 2821/4885L3MBTL1 4710/4885LPAR1 3628/4885
US-10160750-B2 Diamide macrocycles as factor XIa inhibitors TFPI, TFPI2, F11 NPSR1 2821/4885L3MBTL1 4710/4885LPAR1 3628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.